Salute e Benessere
Clinical Chemistry Analyzers Market worth $20.86 billion by 2030 | MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144027310
The clinical chemistry analyzers market is witnessing steady growth, driven mainly by the rising prevalence of chronic and lifestyle-related diseases and an increasing elderly population. The growing adoption of point-of-care testing is further supporting market expansion, as these devices enable faster, more accessible, and convenient diagnostic solutions. Additionally, the ongoing modernization of healthcare infrastructure and the rising demand for efficient laboratory automation are creating new opportunities for market players, fostering innovation and improving overall diagnostic capabilities.
By end users, the clinical chemistry analyzers market is segmented into hospitals & clinics, diagnostic laboratories, research laboratories and institutes, and other end users. In 2024, hospitals & clinics accounted for the largest share of the market. This segment's growth is primarily driven by the increasing incidence of various diseases and disorders, the rising adoption of clinical chemistry analyzers in healthcare facilities, and ongoing technological advancements that enhance diagnostic efficiency and accuracy.
https://www.marketsandmarkets.com/requestsampleNew.asp?id=144027310
The clinical chemistry analyzers market, segmented by test type, comprises basic metabolic panels, liver function panels, lipid profiles, renal function panels, thyroid function panels, electrolyte panels, and specialty chemical tests. The lipid profiles segment recorded the highest growth rate, mainly due to the increasing incidence of obesity and associated health complications such as cardiovascular diseases and metabolic disorders. Growing awareness of preventive healthcare and the importance of regular lipid monitoring has further contributed to the rising demand for lipid profile testing in clinical settings.
The clinical chemistry analyzers market is segmented into five regions: North America , Europe , Asia Pacific , Latin America , and the Middle East & Africa . In 2024, North America accounted for the largest market share. This leading position is driven by factors such as a growing geriatric population, the rising prevalence of chronic and lifestyle-related diseases, supportive government initiatives, increased healthcare spending, well-developed healthcare infrastructure, and the availability of advanced diagnostic instruments.
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144027310
The Top Companies in Clinical Chemistry Analyzers Market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. ( Switzerland ), Siemens Healthineers AG ( Germany ), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), HORIBA Ltd. ( Japan ), Sysmex Corporation ( Japan ), Hitachi, Ltd. ( Japan ), EKF Diagnostics Holdings plc (UK), and QuidelOrtho Corporation (US).
:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-chemistry-analyzers-market-worth-20-86-billion-by-2030--marketsandmarkets-302633834.html